Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

1.60USD
1:16pm EDT
Change (% chg)

$-0.03 (-1.84%)
Prev Close
$1.63
Open
$1.70
Day's High
$1.70
Day's Low
$1.60
Volume
7,662
Avg. Vol
9,668
52-wk High
$3.35
52-wk Low
$1.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.54 30.58
P/E High - Last 5 Yrs. -- 42.02 47.03
P/E Low - Last 5 Yrs. -- 23.71 24.81
Beta 1.56 0.86 0.85
Price to Sales (TTM) 0.13 3.59 8.15
Price to Book (MRQ) -- 3.41 3.78
Price to Tangible Book (MRQ) -- 4.90 5.88
Price to Cash Flow (TTM) -- 19.97 21.39
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.93 1.79
Dividend Yield - 5 Year Avg -- 1.54 1.46
Dividend 5 Year Growth Rate -- -9.11 -6.23
Payout Ratio(TTM) -- 49.56 46.83

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.39 4.30 6.92
Sales (TTM) vs TTM 1 Yr. Ago 4.59 10.08 11.36
Sales - 5 Yr. Growth Rate 18.96 6.98 7.60
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.77 13.37 18.25
EPS (TTM) vs TTM 1 Yr. Ago 68.55 -- --
EPS - 5 Yr. Growth Rate -- 6.42 7.55
Capital Spending - 5 Yr. Growth Rate -70.25 7.23 7.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.82 2.57 2.53
Current Ratio (MRQ) 0.88 3.63 3.58
LT Debt to Equity (MRQ) -- 8.85 11.26
Total Debt to Equity (MRQ) -- 11.63 14.56
Interest Coverage (TTM) -2.77 36.02 31.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 69.85 55.52 55.12
Gross Margin - 5 Yr. Avg. 65.88 53.24 53.21
EBITD Margin (TTM) 18.66 -- --
EBITD - 5 Yr. Avg 2.82 18.74 15.77
Operating Margin (TTM) -21.31 14.38 -2.60
Operating Margin - 5 Yr. Avg. -55.06 14.37 10.94
Pre-Tax Margin (TTM) -45.62 14.67 -0.67
Pre-Tax Margin - 5 Yr. Avg. -72.09 14.60 11.11
Net Profit Margin (TTM) -46.01 11.29 -3.89
Net Profit Margin - 5 Yr. Avg. -68.15 10.92 7.47
Effective Tax Rate (TTM) -- 20.50 20.48
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.17

Efficiency

  Company industry sector
Revenue/Employee (TTM) 844,825 842,714,883 735,010,332
Net Income/Employee (TTM) -388,672 98,299,820 85,647,511
Receivable Turnover (TTM) 4.25 5.50 5.48
Inventory Turnover (TTM) 6.78 2.49 3.59
Asset Turnover (TTM) 0.66 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.33 10.52 10.23
Return on Assets - 5 Yr. Avg. -26.41 11.51 11.03
Return on Investment (TTM) -50.48 13.15 12.84
Return on Investment - 5 Yr. Avg. -36.65 14.93 14.24
Return on Equity (TTM) -- 15.15 15.02
Return on Equity - 5 Yr. Avg. -696.55 16.18 15.57
  1 Year 3 Year 5 Year
Sales % 3.70 6.26 18.96
EPS (TTM) % 66.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.30%
# of Holders: 42
Total Shares Held: 3,521,989
3 Mo. Net Change: 1,254,661
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 4
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.